PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29627448 ↗2018Reported benefit

Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.

MouseEndotoxin/LPSBALB/cIntraperitoneal1 h before lipopolysaccharide and d-galactosamine challenge

Model: Acute liver injury induced by lipopolysaccharide plus d-galactosamine

Maslinic acid reduced histopathological liver damage, serum AST and ALT, inflammatory cytokines, MDA and myeloperoxidase in a dose-dependent manner, lowered hepatic NF-kappaB and raised Nrf2 and HO-1 expression.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.